Paul Grootendorst

Read how they describe their research on their University of Toronto profile.

• The launch and diffusion of new patented medicines by therapeutic value

  Health Affairs Scholar · 2026

• Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries

  BioDrugs · 2025

• The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose

  Osteoporosis International · 2025

• Understanding the Economic Causal Factors Underlying Canadian Drug Shortages

  SSHRC · 2024 · Principal investigator

  $10,000

• The effects of retirement on dental insurance coverage and oral health for seniors in Canada: An empirical analysis

  CIHR · 2010 · Nominated PI

  $49,900

• Controlled Radiography for Ankle Injury Cases in Kids in the Emergency Department (CRACKED) Study: Implementation of Best Evidence for Imaging of Paediatric Ankle Injuries

  CIHR · 2008 · Co-investigator

  $100,000